Shares of Nebius Group N.V. (NASDAQ:NBIS – Get Free Report) gapped down prior to trading on Thursday . The stock had previously closed at $24.45, but opened at $21.60. Nebius Group shares last traded at $22.96, with a volume of 3,207,372 shares trading hands.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on NBIS shares. BWS Financial reiterated a “buy” rating and set a $60.00 price objective on shares of Nebius Group in a research note on Tuesday, March 4th. DA Davidson initiated coverage on shares of Nebius Group in a research report on Tuesday, February 25th. They set a “buy” rating and a $50.00 price target on the stock.
Nebius Group Price Performance
Hedge Funds Weigh In On Nebius Group
An institutional investor recently bought a new position in Nebius Group stock. Centaurus Financial Inc. purchased a new position in shares of Nebius Group N.V. (NASDAQ:NBIS – Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 343,130 shares of the company’s stock, valued at approximately $9,505,000. Centaurus Financial Inc. owned approximately 0.15% of Nebius Group as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 21.90% of the company’s stock.
Nebius Group Company Profile
Nebius Group N.V., a technology company, builds intelligent products and services powered by machine learning and other technologies to help consumers and businesses navigate the online and offline world. The company’s services include Nebius AI, an AI-centric cloud platform that offers infrastructure and computing capability for AI deployment and machine-learning oriented solutions; and Toloka AI that offers generative AI (GenAI) solutions at every stage of the GenAI lifecycle, such as data annotation and generation, model training and fine-tuning, and quality assessment of large language model for accuracy and reliability.
Further Reading
- Five stocks we like better than Nebius Group
- Top Biotech Stocks: Exploring Innovation Opportunities
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- What is the S&P 500 and How It is Distinct from Other Indexes
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
- Insider Trading – What You Need to Know
- Big Buybacks: 3 Large Caps Exceed 5% Repurchase Power
Receive News & Ratings for Nebius Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nebius Group and related companies with MarketBeat.com's FREE daily email newsletter.